Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Farge

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Blood|May 21, 2011
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working PartyThomas Daikeler, Myriam Labopin, Massimo Di Gioia, et al.
Rheumatology (Oxford, England)|July 23, 2021
Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial Autologous AD-SVF versus placebo in systemic sclerosisAurélie Daumas, Jérémy Magalon, Elisabeth Jouve, et al.
Fundamental & Clinical Pharmacology|August 3, 2020
Medication non-adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular TherapyStephanie Belaiche, Bertrand Décaudin, Alexandre Caron, et al.
Cytotherapy|December 20, 2025
Fate and function of exogenously administered mesenchymal stromal cells: current insights and future directionsAli Shokoohmand, Nikita M Patel, Lorena Braid, et al.
Plos One|March 23, 2016
Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with CyclophosphamideAlexandra Audemard-Verger, Nicolas Martin Silva, Céline Verstuyft, et al.
Clinical and Experimental Rheumatology|May 19, 2011
Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi techniqueJoerg H W Distler, Suzana Jordan, Paolo Airo, et al.
Annals of the Rheumatic Diseases|June 17, 2010
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnthony J Tyndall, Bettina Bannert, Madelon Vonk, et al.
JAMA|July 25, 2014
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trialJacob M van Laar, Dominique Farge, Jacob K Sont, et al.
Autoimmunity Reviews|April 25, 2017
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosusJean-François Kleinmann, Florence Tubach, Véronique Le Guern, et al.
Rheumatology (Oxford, England)|December 6, 2017
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational StudySébastien Peytrignet, Christopher P Denton, Mark Lunt, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Blood|May 21, 2011
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working PartyThomas Daikeler, Myriam Labopin, Massimo Di Gioia, et al.
Rheumatology (Oxford, England)|July 23, 2021
Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial Autologous AD-SVF versus placebo in systemic sclerosisAurélie Daumas, Jérémy Magalon, Elisabeth Jouve, et al.
Fundamental & Clinical Pharmacology|August 3, 2020
Medication non-adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular TherapyStephanie Belaiche, Bertrand Décaudin, Alexandre Caron, et al.
Cytotherapy|December 20, 2025
Fate and function of exogenously administered mesenchymal stromal cells: current insights and future directionsAli Shokoohmand, Nikita M Patel, Lorena Braid, et al.
Plos One|March 23, 2016
Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with CyclophosphamideAlexandra Audemard-Verger, Nicolas Martin Silva, Céline Verstuyft, et al.
Clinical and Experimental Rheumatology|May 19, 2011
Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi techniqueJoerg H W Distler, Suzana Jordan, Paolo Airo, et al.
Annals of the Rheumatic Diseases|June 17, 2010
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnthony J Tyndall, Bettina Bannert, Madelon Vonk, et al.
JAMA|July 25, 2014
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trialJacob M van Laar, Dominique Farge, Jacob K Sont, et al.
Autoimmunity Reviews|April 25, 2017
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosusJean-François Kleinmann, Florence Tubach, Véronique Le Guern, et al.
Rheumatology (Oxford, England)|December 6, 2017
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational StudySébastien Peytrignet, Christopher P Denton, Mark Lunt, et al.
Pageof 20